Evaluation of the safety profile of prolonged-release EE/DNG oral contraceptives: a critical appraisal
Recent publications have suggested that a novel prolonged-release formulation of ethinylestradiol (EE) 20 µg and dienogest (DNG) 2 mg offers improved bleeding profiles and minimal impact on coagulation. These conclusions, however, are based on incomplete safety assessments and potentially misleading...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Taylor & Francis Group
2025-12-01
|
| Col·lecció: | Gynecological Endocrinology |
| Matèries: | |
| Accés en línia: | https://www.tandfonline.com/doi/10.1080/09513590.2025.2571648 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|